MD FRCP FRCOphth FHEA DCH DRCOG DO
- Tutor and Senior Research Fellow, Harris Manchester College
Prof. Peter Scanlon has been Clinical Director for the English NHS Diabetic Eye Screening Programme since 2003, and he has, with the support and co-operation of colleagues, moved screening from limited ad hoc delivery of services to systematic quality assured processes for screening, assessment and treatment across all of England to 2.3 million people with diabetes. Dr Scanlon also holds an appointment as a Senior Research Fellow and Medical Tutor at Harris Manchester College, University of Oxford, and as Visiting Professor at the University of Gloucestershire. Dr Scanlon is Lead Author of the textbook ‘Practical Manual of Diabetic Retinopathy Management’ and has written the Diabetic Retinopathy Chapter for the Textbook of Diabetes, 4th Edition (both Wiley Blackwell).
His research interests lie in the Screening, Epidemiology, Assessment and Treatment of Diabetic Retinopathy and he has published extensively in these areas.
Lois N. and of the EMERALD Study Group None., (2021), Ophthalmology, 128, e46 - e47
Standardisation of Optical Coherence Tomography Angiography Imaging Biomarkers in Diabetic Retinal Disease.
Vujosevic S. et al, (2021), Ophthalmic Res
A Multitask Deep-Learning System to Classify Diabetic Macular Edema for Different Optical Coherence Tomography Devices: A Multicenter Analysis.
Tang F. et al, (2021), Diabetes Care
Prevalence and incidence of diabetic retinopathy (DR) in the UK population of Gloucestershire.
Scanlon PH. et al, (2021), Acta Ophthalmol
Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: the EMERALD diagnostic accuracy study
Lois N. et al, (2021), Health Technology Assessment, 25, 1 - 104